Last edition
News about "DRAGEN MRD analysis"
Illumina Unveils Whole-Genome Sequencing Solution for Sensitive MRD Detection
Illumina has launched the first distributed Whole-Genome Sequencing (WGS) solution for highly sensitive Molecular Residual Disease (MRD) research, enabling faster and more flexible detection of the disease during and after treatment while expanding its next-generation oncology sequencing portfolio.
DRAGEN MRD Analysis | 02/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members